Skip to main content
SpringerLink
Log in

Perillyl Alcohol: A Pharmacotherapeutic Report

Molecular Genetics of Malignant Gliomas Disclose Targets for Perillyl Alcohol

  • Chapter
  • First Online:
Bioactive Essential Oils and Cancer

  • 1684 Accesses

Abstract

Tumors of glial origins such as glioblastoma multiforme (GBM) comprise majority of human brain tumors. Despite advances in surgery, radiation, and chemotherapy, the prognosis for patients with malignant gliomas has not improved, emphasizing the need for a search for new chemotherapeutic drugs. The biological characteristics of these tumors are exemplified by prominent proliferation, active invasiveness, and rich angiogenesis. This is mainly due to highly deregulated signaling pathways in the tumor. Studies of these signaling pathways have greatly increased our understanding of the biology and clinical behavior of malignant gliomas. An integrated view of signal transduction will provide a more useful approach in designing novel therapies for this devastating disease. Deregulated p21-Ras function, as a result of mutation, overexpression, or growth factor-induced overactivation, contributes to the growth of GBM. The monoterpene perillyl alcohol (POH) has preventive and therapeutic effects in a wide variety of preclinical tumor models and is currently under phase I and phase II clinical trials. As inhibition of posttranslational isoprenylation of Ras, a family of proteins that are involved in signal transduction is among the drug-related activities observed in this compound; POH may be a potential chemotherapeutic agent for GBM. In vitro studies showed that POH was cytotoxic to Temozolomide (TMZ)-resistant as well as TMZ-sensitive glioma cells, and this effect was independent of O6-methylguanine-DNA methyltransferase (MGMT) expression. POH induced cytotoxicity, in part, through the endoplasmic reticulum (ER) stress pathway as shown by the increased expression of glucose-regulated protein-78 (GRP78), activating transcription factor 3 (ATF3) and C/EBP-homologous protein (CHOP). In addition, POH impeded survival pathways, such as mTOR and Ras. As well, POH reduced the invasive capacity of sensitive and resistant glioma cells. In this chapter, we summarize the current understanding of malignant gliomas signaling pathways with a focus on effect of intranasal delivery of POH in patients with relapsed malignant gliomas. Our results indicate that long-term POH inhalation chemotherapy is a safe and noninvasive strategy efficient for recurrent malignant glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ariazi EA, Satomi Y, Elis MJ, Haag JD, Shi W, Satler CA, Gould MN (1999) Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Res 59:1917–1928

    CAS  PubMed  Google Scholar 

  • Bailey HH, Attia S, Love RR, Fass T, Chappell R, Tutsch K, et al (2008) Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. Cancer Chemoth Pharm 62:149–157

    Article  CAS  Google Scholar 

  • Belanger JT (1998) Perillyl alcohol: applications in oncology. Altern Med Rev 3:445–448

    Google Scholar 

  • Cho HY, Wang W, Jhaveri N et al (2012) Perillyl alcohol for the treatment of temozolomide-resistant gliomas. Mol Cancer Ther 11: 2462–2472

    Article  CAS  PubMed  Google Scholar 

  • Da Fonseca CO, Silva JT, Lins IR, Simão M, Arnobio A, Futuro D, Quirico-Santos T (2009) Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol. Invest New Drugs 27(6):557–564

    Article  CAS  PubMed  Google Scholar 

  • Ding H, Roncari L, Shannon P, Wu X, Lau N, Karaskova J, Gutmann DH, Squire JA, Nagy A, Guha A (2001) Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 61: 3826–3836

    CAS  PubMed  Google Scholar 

  • Dontula R, Dinasarapu A, Chetty C, Pannuru P, Herbert E, Ozer H, Lakka SS (2013) MicroRNA 203 Modulates glioma cell migration via robo1/ERK/MMP-9 signaling. Genes Cancer 4(7–8):285–296.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Duelund L, Amiot A, Fillon A, Mouritsen OG (2012) Influence of the active compounds of Perilla frutescens leaves on lipid membranes. J Nat Prod 75(2):160–166

    Article  CAS  PubMed  Google Scholar 

  • England B, Huang T, Karsy M (2013) Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme. Tumour Biol 34(4):2063–2074.

    Article  CAS  PubMed  Google Scholar 

  • Farrell CJ, Plotkin SR (2007) Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurol Clin 25(4):925–946, viii

    Article  PubMed  Google Scholar 

  • Feldkamp MM, Lau N, Guha A (1999) Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, proapoptoic and anti-angiogenic effects. Oncogene 18:7514–7526

    Article  CAS  PubMed  Google Scholar 

  • Feldkamp MM, Lau N, Roncari L, Guha A (2001) Isotype-specific Ras. GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status. Cancer Res 61:4425–4431

    CAS  PubMed  Google Scholar 

  • Fernandes J, Fonseca CO, Teixeira A, Gatass CR (2005) Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells. Oncol Rep 13(5):943–947

    CAS  PubMed  Google Scholar 

  • Fischer Jde S, Liao L, Carvalho PC, Barbosa VC, Domont GB, Carvalho Mda G, Yates JR 3rd (2010) Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol. J Proteomics 73(5):1018–27.

    Article  Google Scholar 

  • Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430

    Article  CAS  PubMed  Google Scholar 

  • González-Gómez P, Sánchez P, Mira H (2011) MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme. Mol Neurobiol 44(3):235–249

    Article  PubMed  Google Scholar 

  • Guha A, Feldkamp MM, Lau N, Boss G, Pawson A (1997) Proliferation of human malignant astrocytomas are dependent on Ras activation. Oncogene 15:2755–2765

    Article  CAS  PubMed  Google Scholar 

  • Heldin CH, Lennartsson J (2013) Structural and functional properties of platelet-derived growth factor and stem cell factorreceptors. Cold Spring Harb Perspect Biol 5(8):a009100

    Article  Google Scholar 

  • Itoh T, Kaibuchi K, Masuda T, Yamamoto T, Matsuura Y, Maeda A, Shimizu K, Takai Y (1993) The post-translational processing of ras p21 is critical for its stimulation of mitogen-activated protein kinase. J Biol Chem 15:3025–3028

    Google Scholar 

  • Jeffers L (1995) The effect of perillyl alcohol on the proliferation of human prostatic cell lines. Proc Am Assoc Cancer Res 36:303

    Google Scholar 

  • Jiang K, Coppola D, Crespo NC, Nicosia SV, Hamilton AD, Sebti SM, Cheng JQ (2000) The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis. Mol Cell Biol 20:139–148

    Article  PubMed Central  PubMed  Google Scholar 

  • Karp JE, Kaufmann SH, Adjei AA, Lancet JE, End DW (2001) Current status of clinical trials of farnesyltransferase inhibitors. Curr Opin Oncol 3:470–476

    Article  Google Scholar 

  • Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61(3):215–225

    PubMed  Google Scholar 

  • Levin VA (1999) Chemotherapy for brain tumors of astrocytic and oligodenglial lineages: the past decades and when are heading. Neuro-oncology 1:69–80

    PubMed Central  CAS  PubMed  Google Scholar 

  • Mills JJ, Chari SS, Boyer IJ, Gould MN, Jirtle RL (1995) Induction apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 55:979–983

    CAS  PubMed  Google Scholar 

  • Mischel PS, Cloughesy TF (2003) Targeted molecular therapy of GBM. Brain Pathol 13(1):52–61

    Article  PubMed  Google Scholar 

  • Mo H, Elson CE (2004) Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 229:567–585

    CAS  Google Scholar 

  • Ohgaki H et al (2007) Genetic pathways to glioblastoma: a population-based study. Am J Pathol 170(5):1445–1453

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16:15

    Google Scholar 

  • Rajesh D, Stenzel RA, Howard SP (2003) Perillyl alcohol as a radio-/chemosensitizer in malignant glioma. J Biol Chem 19:35968–35978

    Article  Google Scholar 

  • Reddy BS, Wang CX, Samaha H, et al (1997) Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57:420–425

    CAS  PubMed  Google Scholar 

  • Sahin MB, Perman SM, Jenkins G, Clark SS (1999) Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines. Leukemia 13:1581–1589

    Article  CAS  PubMed  Google Scholar 

  • Teruszkin I, Alves S, Silva HN, Curie CM, Bozza M, Fonseca CO, Da Costa CMG (2002) Effects of perillyl alcohol in glial cell line in vitro and anti-metastatic activity in chorioallantoic membrane model. Int J Mol Med 10:785–788

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Fluminense Federal University, Niterói, RJ, Brazil

    Clovis O Da Fonseca

  2. Department of Cell and Molecular Biology, Institute of Biology, Fluminense Federal University, Niterói, RJ, Brazil

    Thereza Quirico-Santos

Authors
  1. Clovis O Da Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thereza Quirico-Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clovis O Da Fonseca .

Editor information

Editors and Affiliations

  1. Federal University of Paraiba, João Pessoa, Paraíba, Brazil

    Damião Pergentino de Sousa

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Da Fonseca, C., Quirico-Santos, T. (2015). Perillyl Alcohol: A Pharmacotherapeutic Report. In: de Sousa, D. (eds) Bioactive Essential Oils and Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-19144-7_14

Download citation

Publish with us

Policies and ethics

Search

Navigation